SYNH

Syneos Health Inc.

Price

return (12m)

p/e

62.97

p/bv

1.28

DIVIDEND YIELD

0.00%

SYNH price

Syneos Health

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment SYNH

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals SYNH

Valuation

P/E

62.97

Sector 1.08

Industry 3.46

P/BV

1.28

Sector 1.86

Industry 2.13

P/Revenue (PSR)

0.83

Sector 1.54

Industry 1.72

EV/EBITDA

131.10

Sector -46.43

Industry 1.72

EV/EBIT

-1,257.20

Sector -49.92

Industry -4.29

P/EBITDA

21.31

Sector -31.92

Industry -53.68

P/EBIT

-131.01

Sector -43.90

Industry -50.97

P/Total Assets

0.56

Sector 0.85

Industry 0.96

P/Net Current Assets

Sector -25.98

Industry -11.19

P/Working Capital

Sector -3.94

Industry 2.92

EPS

0.68

Sector -0.70

Industry -0.60

BVPS

33.48

Sector 4.54

Industry 4.74

Efficiency

Gross Margin

40.92%

Sector 49.38%

Industry 50.68%

EBITDA Margin

3.93%

Sector -280.65%

Industry -57.47%

EBIT Margin

-0.41%

Sector -163.23%

Industry -56.25%

Operating Margin

4.41%

Sector -19.46%

Industry -25.80%

Net Profit Margins

1.31%

Sector -23.67%

Industry -29.17%

Asset Turnover

0.17

Sector 0.13

Industry 0.15

Profitability

ROE

2.04%

Sector -23.63%

Industry -22.30%

ROA

0.88%

Sector -24.09%

Industry -24.15%

ROIC

Sector -584.46%

Industry -96.49%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

Sector 1.90

Industry 1.98

Net Debt / EBITDA

47.64

Sector -23.21

Industry -2.21

Net Debt / EBIT

-456.79

Sector -11.18

Industry -1.50

Net Debt / Equity

0.73

Sector -0.63

Industry -0.29

Gross Debt / Equity

0.76

Sector -0.72

Industry -0.82

Equity/Assets

0.43

Sector 0.46

Industry 0.47

Liabilities/Assets

0.43

Sector 0.50

Industry 0.52

Growth

5Y Revenue CAGR

0.78%

Sector -

Industry -

5Y Earnings CAGR

-21.23%

Sector -

Industry -

Fundamentals SYNH

DRAG THE FRAME TO SEE MORE DATA

FAIR VALUE OF Syneos Health ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$0.00

Fair Value

$22.63

Upside

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Assets	Price ($)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
SYNH Syneos Health Inc.	$0.00	-	0.00%	62.97	1.28	2.04%	1.31%
TMO Thermo Fisher Scientific Inc.	$651.98	21.45%	0.28%	34.69	4.59	13.22%	15.04%
DHR Danaher Corporation	$217.46	7.34%	0.67%	37.74	2.87	7.61%	15.95%
WAT Waters Corporation	$429.13	29.86%	0.00%	251.30	2.75	1.09%	3.58%
IQV IQVIA Holdings Inc.	$258.88	28.89%	0.00%	31.12	6.79	21.82%	8.10%
SHC Sotera Health Company	$17.83	10.88%	0.00%	31.95	7.85	24.56%	13.44%
CGEN Compugen Ltd.	$2.15	20.11%	0.00%	8.06	2.50	31.01%	36.12%
JNJ Johnson & Johnson	$256.48	38.27%	2.06%	29.27	7.25	24.76%	21.48%
LLY Eli Lilly and Compay	$1,169.60	39.52%	0.59%	38.06	30.01	78.84%	33.53%
ISRG Intuitive Surgical Inc.	$415.41	-5.79%	0.00%	44.62	7.65	17.15%	28.44%
SNY Sanofi	$40.23	-15.00%	4.45%	3.72	0.69	18.43%	14.25%
NVS Novartis AG	$143.11	10.90%	2.22%	20.91	6.36	30.41%	23.29%
ABT Abbott Laboratories	$98.49	-23.95%	2.53%	31.55	3.35	10.61%	11.65%
MDT Medtronic PLC	$87.75	-7.12%	3.30%	21.10	2.17	10.29%	13.93%
GSK GlaxoSmithKline PLC	$46.54	11.91%	3.77%	14.44	4.08	28.24%	14.54%
CVS CVS Health Corporation	$87.80	18.35%	3.09%	22.49	1.38	6.12%	1.18%
BSX Boston Scientific Corp.	$41.63	-56.59%	0.00%	17.31	2.55	14.73%	17.49%
TMDX TransMedics Group Inc.	$79.00	-31.41%	0.00%	17.68	5.18	29.28%	22.69%
IDXX IDEXX Laboratories Inc.	$513.14	-18.20%	0.00%	36.04	25.47	70.67%	25.03%
RMD ResMed Inc.	$226.73	-19.12%	1.12%	20.92	4.84	23.13%	26.94%
HCA HCA Healthcare Inc.	$445.01	2.19%	0.71%	13.82	-29.45	-213.15%	8.77%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

SYNH - Historical Dividends

no dividend paid in the period.

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

ABOUT Syneos Health

Syneos Health Inc.

Average Investor10 user rating

4.0 (0 people)

United States

16 years

Founded: 2010

2014

Time since IPO - 12 years

6.800

Employees

Syneos Health Inc. (United States) is listed on the Nasdaq and has a market capitalization of $4.48 billion, with shareholders equity totaling $3.49 billion.

The company employs approximately 6.800 people and operates in the Health sector, within the Life Science Tools and Services industry.

Over the past 12 months, Syneos Health Inc. reported $5.42 billion in revenue, generating net income of $71.22 million.

Key financial metrics include a P/E ratio of 62.97, a price-to-book (P/B) ratio of 1.28, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker SYNH.

Market cap

$4.48 billion

Net worth

$3.49 billion

$3,493,754,000.00

Assets

$8.08 billion

$8,075,381,000.00

Total Shares Outstanding

104.34 million

104,344,000

Average Daily Trading Volume

$1.29 million

$1,293,527.04

Sector

Health

Industry

Life Science Tools and Services

SYNH

SYNH revenue and profits

Financial Results SYNH

DRAG THE FRAME TO SEE MORE DATA

SYNH cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$87.80 18,94% (12M)

P/E

22.49

3.09%

ROE

6.12%

P/BV

1.38

CI - Cigna

$281.03 --6,13% (12M)

P/E

10.33

2.31%

ROE

16.04%

P/BV

1.66

CNC - Centene

$64.54 70,61% (12M)

P/E

-6.05

0.00%

ROE

-22.53%

P/BV

1.36

HUM - Humana

$387.12 35,43% (12M)

P/E

35.89

0.93%

ROE

6.63%

P/BV

2.38

SNY - Sanofi

$40.23 --14,35% (12M)

P/E

3.72

4.45%

ROE

18.43%

P/BV

0.69

JNJ - Johnson & Johnson

$256.48 37,27% (12M)

P/E

29.27

2.06%

ROE

24.76%

P/BV

7.25

LLY - Eli Lilly

$1,169.60 37,60% (12M)

P/E

38.06

0.59%

ROE

78.84%

P/BV

30.01

HCA - HCA Healthcare

$445.01 6,75% (12M)

P/E

13.82

0.71%

ROE

-213.15%

P/BV

-29.45